Central drugs standards control organization

Govt expert panel recommends JV firm’s vaccine for pneumococcal infections

The Central Drugs Standards Control Organization's (CDSCO) Subject Expert Committee (SEC) recommended on Tuesday that Aurobindo Pharma's joint venture business Tergene be granted authorization to produce and distribute a 15-valent pneumococcal Polysaccharide conjugate vaccine (PCV15). The vaccination protects against pneumococcal infections in newborns, young children, and adults. In a statement...